Authors: Galmarini, CM Falette, N Tabone, E Levrat, C Britten, R Voorzanger-Rousselot, N Roesch-Gateau, O Vanier-Viornery, A Puisieux, A Dumontet, C

Citation: Cm. Galmarini et al., Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity, BR J CANC, 85(6), 2001, pp. 902-908

Authors: Blay, JY Thomachot, MC Alberti, L Bachelot, T Voorzanger-Rousselot, N Puisieux, I Odin, L Menetrier-Caux, C

Citation: Jy. Blay et al., Immunotherapy of cancers - New approaches, B CANCER, 87(1), 2000, pp. 97-106